Evidence map›Paper›PMID 36900663›Full record

ArticleHealthcare (Basel, Switzerland)2023

Determinants of Acquisition, Persistence, and Clearance of Oncogenic Cervical Human Papillomavirus Infection in the Philippines Using a Multi-Omics Approach: DEFEAT HPV Study Protocol.

Sheriah Laine M de Paz-Silava, Ian Kim B Tabios, Ourlad Alzeus G Tantengco, Fresthel Monica M Climacosa, Clarissa L Velayo, Ryan C V Lintao, Leslie Faye T Cando, Glenmarie Angelica S Perias, Maria Isabel C Idolor, Abialbon G Francisco and 3 more

Full text read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sheriah Laine M de Paz-SilavaMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
Ian Kim B TabiosMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0002-0956-334X
Ourlad Alzeus G TantengcoMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0002-4535-8837
Fresthel Monica M ClimacosaMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
Clarissa L VelayoMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0001-7727-2838
Ryan C V LintaoMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0001-7192-2377
Leslie Faye T CandoMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0001-6089-9861
Glenmarie Angelica S PeriasMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0002-8334-0224
Maria Isabel C IdolorMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
Abialbon G FranciscoMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
Charlene Divine M CatralMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.ORCID 0000-0003-3152-8484
Charlotte M ChiongMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
Leslie Michele M DalmacioMulti-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.

Funding

Department of Science and Technology - Philippine Council for Health Research and Development. None.
6 · The paper itself

Abstract

HPV infection is one of the most studied risk factors in cervical cancer-the second most common cancer site and cause of death due to cancer in the Philippines. However, there is a lack of population-based epidemiological data on cervical HPV infection in the Philippines. Local reports on co-infections with other lower genital tract pathogens, commonly reported globally, are also lacking, which emphasizes the need to increase efforts in targeting HPV prevalence, genotype, and distribution. Hence, we aim to determine the molecular epidemiology and natural history of HPV infection among reproductive-age Filipino women using a community-based prospective cohort design. Women from rural and urban centers will be screened until the target sample size of 110 HPV-positive women (55 from rural sites and 55 from urban sites) is reached. Cervical and vaginal swabs will be collected from all screened participants. For HPV-positive patients, HPV genotypes will be determined. One hundred ten healthy controls will be selected from previously screened volunteers. The cases and controls will comprise the multi-omics subset of participants and will be followed up after 6 and 12 months for repeat HPV screening. Metagenomic and metabolomic analyses of the vaginal swabs will also be performed at baseline, after 6 months, and after 12 months. The results of this study will update the prevalence and genotypic distribution of cervical HPV infection among Filipino women, determine whether the current vaccines used for HPV vaccination programs capture the most prevalent high-risk HPV genotypes in the country, and identify vaginal community state types and bacterial taxa associated with the natural history of cervical HPV infection. The results of this study will be used as the basis for developing a biomarker that can help predict the risk of developing persistent cervical HPV infection in Filipino women.

Indexed as

cervical cancerepidemiologyhuman papillomavirusPhilippinesscreeningtreatmentvaccination

Identifiers

PMID36900663
PMCPMC10001359

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read38
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.